Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors

NCT04157985 is registered in ClinicalTrials.gov with Dan Zandberg as lead sponsor.

NCT NCT04157985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04157985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
Lead sponsor
Dan Zandberg
Phase
Phase 3
Overall status
Completed
Start date
November 15, 2019
Completion date
November 7, 2025
Enrollment
161 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors, anal cancer, bladder cancer, cervical cancer, cholangiocarcinoma, colorectal cancer, gastric cancer, hepatocellular carcinoma, hnscc, melanoma, merkel cell carcinoma, nsclc, renal cancer